Dr Ron Behrens BSc MB ChB MD FRCP
About Ron Behrens
Travel medicine, Travellers' malaria, Occupational health of overseases workers. Evidence based policy development. Vaccinology.
- Ron Behrens's Contacts
- Keppel Street
- WC1E 7HT
- T: 0207 927 2661
I undertook postgraduate training in gastroenterology and nutrition at the University of Cambridge. I have undertaken overseas research in various countries, including The Gambia, Bangladesh, Indonesia and Tanzania. I have advised multi-nationals organisations on health issues and policy in overseas sites and contributed to health policy and safety of overseas workers. I continue to contribute to health policy bodies including, the British Defence forces, NATHNaC and W.H.O. on health threats and diseases associated with travel. My current appointment is as the only NHS Consultant in Travel Medicine, based in theHospital for Tropical Diseases’ Travel Clinic (part time) and as a Senior Lecturer,
I contribute to a number of training and educational programmes including the Diploma in Tropical Medicine and Hygiene and teach on a number of master programmes. I provide in service training on travel medicine in my travel clinic.
I run an annual 1 week short course in Travel Medicine, which is now in its 13th year. I established the 1st online multimedia course e-learning course in travel medicine which is about to be updated.
I, with Martin Holland, am the departmental research degree co-ordinator in the department clinical research.
My research interest include malaria and its prevention, focusing on the epidemiological risk in travellers to varied destinations and generating preventative policies based on evidence around the epidemiology of imported malaria.
I have undertaken clinical trials of novel travel diarrhoea vaccines, malaria chemoprophylaxis and malaria treatment drugs.
I contribute to surveillance of imported infectious diseases through a leadership role in a European clinical based network, TropNet.
I have published over 100 peer review publications covering a range of travel health issues, including the economics and effectiveness of vaccines, malaria prophylaxis, patterns diseases and their relationship to behaviour of travellers, public health management of imported infectious diseases and studies of vaccine efficacy. Recent publications have focused on creating and evidence base for travel associated risks. My recent research has been in collaboration with ARCTEC, exploring the management of insect bites. I have, with the Dept of Clinical Psychology at UCL, completed a study of the effect of needle anxiety in travellers on their comprehension and recall of advice.
I have worked in collaboration with colleagues in the Dept. of Immunology on the NK T-cell responses following administration of rabies and influenza vaccines, via different routes, to volunteers.
- Clinical guidelines
- Clinical trials
- Economic evaluation
- Health policy
- Health promotion
- Occupational health
- Policy analysis
Disease and Health Conditions
- Diarrhoeal diseases
- Infectious disease
- Tropical diseases
- Antimalarial Drug Resistance
- Asylum Seekers
- B Cell Immunology
- Clinical Tropical Medicine
- Conjugate Vaccines
- Emerging Infectious Diseases
- Infectious disease policy
- Plasmodium falciparum gametocyte biology/immunity
- Public health
- after-bite treatment
- economics of health care
- risk analysis
- travel health
Vaccine-Preventable Travel Health Risks: What Is the Evidence-What Are the Gaps?
Steffen, R.; Behrens, R.H.; Hill, D.R.; Greenaway, C.; Leder, K.
Journal of Travel Medicine, 2015; 22(1):1-12
Mosquito repellents for travellers.
Stanczyk, N.M. ; Behrens, R.H. ; Chen-Hussey, V. ; Stewart, S.A. ; Logan, J.G. ;
BMJ, 2015; 350:h99
Does public subsidy of the cost of malaria chemoprophylaxis reduce imported malaria? A comparative policy analysis.
Neave, P.E. ; Taylor, S. ; Behrens, R.H. ;
Malar J, 2013; 12(1):238
The challenges of disease risk ascertainment using accessible data sources for numbers of travelers.
Behrens, R.H. ; Carroll, B. ;
J Travel Med, 2013; 20(5):296-302
Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.
Behrens, R.H. ; Cramer, J.P. ; Jelinek, T. ; Shaw, H. ; von Sonnenburg, F. ; Wilbraham, D. ; Weinke, T. ; Bell, D.J. ; Asturias, E. ; Pauwells, H.L. ; Maxwell, R. ; Paredes-Paredes, M. ; Glenn, G.M. ; Dewasthaly, S. ; Stablein, D.M. ; Jiang, Z.D. ; Dupont, H.L. ;
Lancet Infect Dis, 2013;
Malaria:: an update for physicians.
Nadjm, B. ; Behrens, R.H. ;
Infect Dis Clin North Am, 2012; 26(2):243-59
Travel trends and patterns of travel-associated morbidity.
Behrens, R.H. ; Carroll, B. ;
Infect Dis Clin North Am, 2012; 26(3):791-802
NK Cells as Effectors of Acquired Immune Responses: Effector CD4+ T Cell-Dependent Activation of NK Cells Following Vaccination.
Horowitz, A.; Behrens, R.H.; Okell, L.; Fooks, A.R.; Riley, E.M.;
J Immunol, 2010; 185(5):2808-18
- → View all Dr Ron Behrens 's publications